{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:46:31Z","timestamp":1780710391517,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s43441-025-00759-1","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:34:41Z","timestamp":1740184481000},"page":"471-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Catering the Need of Drug Manufacturing Standard in India: An Update to Indian Pharmacopoeia"],"prefix":"10.1007","volume":"59","author":[{"given":"Bikash Kumar","family":"Sah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"759_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.12688\/f1000research.23057.1","volume":"9","author":"PJ Guerin","year":"2020","unstructured":"Guerin PJ, Singh-Phulgenda S, Strub-Wourgaft N. The consequence of COVID-19 on the global supply of medical products: why Indian generics matter for the world? F1000Research. 2020;9:225.","journal-title":"F1000Research"},{"issue":"12","key":"759_CR2","doi-asserted-by":"publisher","first-page":"101825","DOI":"10.1016\/j.jsps.2023.101825","volume":"31","author":"GPS Jadaun","year":"2023","unstructured":"Jadaun GPS, Rastogi S, Kumar A, Chauhan J, Sharma SK, Kumar M, et al. Ensuring the quality of medicines in India: an update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia. Saudi Pharm J. 2023;31(12):101825.","journal-title":"Saudi Pharm J"},{"key":"759_CR3","unstructured":"Indian Pharmacy. Pharma Companies in India| IBEF [Internet]. [cited 2024 Sep 29]. Available from: https:\/\/www.ibef.org\/industry\/pharmaceutical-india"},{"key":"759_CR4","unstructured":"Indian Pharmaceuticals Industry Analysis Presentation| IBEF [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/www.ibef.org\/industry\/indian-pharmaceuticals-industry-analysis-presentation"},{"key":"759_CR5","unstructured":"Pharmaceuticals Companies in India [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/www.ibef.org\/industry\/pharmaceutical-india\/showcase"},{"key":"759_CR6","unstructured":"Indian Pharmacy. Pharma Companies in India| IBEF [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/www.ibef.org\/industry\/pharmaceutical-india"},{"key":"759_CR7","unstructured":"India Pharmaceutical. Market Analysis| Industry Growth, Size & Forecast Report [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/www.mordorintelligence.com\/industry-reports\/pharmaceuticals-industry-in-india"},{"key":"759_CR8","unstructured":"Government of India. Annual Report 2022-23 Final-3. Annual Report, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals. 2023."},{"key":"759_CR9","unstructured":"Alliance IP. The Indian pharmaceutical industry-the way forward Contents. 2030;(June)."},{"key":"759_CR10","first-page":"1","volume":"1940","author":"Ministry of Health and Family Welfare","year":"2016","unstructured":"Ministry of Health and Family Welfare. The drugs and cosmetics Act and rules. Gazaette India. 2016;1940:1\u2013635.","journal-title":"Gazaette India"},{"key":"759_CR11","unstructured":"functions [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/About-us\/Functions\/"},{"key":"759_CR12","unstructured":"clinical Trials [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/Clinical-Trial\/clinical-trials\/"},{"key":"759_CR13","unstructured":"Home. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Sep 30]. Available from: https:\/\/ipc.gov.in\/"},{"key":"759_CR14","unstructured":"Indian Pharmacopoeia 2022 - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Sep 30]. Available from: https:\/\/ipc.gov.in\/mandates\/indian-pharmacopoeia\/indian-pharmacopoeia-2022.html"},{"key":"759_CR15","unstructured":"General Notices of IP -. Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/ipc.gov.in\/mandates\/indian-pharmacopoeia\/general-notices-of-ip.html"},{"key":"759_CR16","unstructured":"Monographs Inclusion-Exclusion Criteria. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/ipc.gov.in\/mandates\/indian-pharmacopoeia\/monographs-inclusion-exclusion-criteria.html"},{"key":"759_CR17","unstructured":"Ministry of Health and Family Welfare. Indian Pharmacopoeia Government India. 2022;I:381\u20133."},{"key":"759_CR18","unstructured":"Indian pharmacopoeia commission. Indian pharmacopoeia government of india,ministry of health & family welfare. Vol. II. 2022. 1603\u20131604 p."},{"key":"759_CR19","unstructured":"Ip. Indian Pharmacopoeia. Vol. 3, Appendix 9.4. 1996. 110\u2013117 p."},{"key":"759_CR20","unstructured":"Monographs V, INDIAN_PHARMACOPOEI. A 2022 IV veterinary monographs Government of India Ministry of Health & Family Welfare. Vol. IV. 2022."},{"key":"759_CR21","unstructured":"IP Online. Indian Pharmacopoeia Commission. [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/iponline.ipc.gov.in\/jspui\/indian-pharmacopoeia\/history.jsp"},{"key":"759_CR22","unstructured":"Indian Pharmacopoeia 2022 - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 2]. Available from: https:\/\/ipc.gov.in\/mandates\/indian-pharmacopoeia\/indian-pharmacopoeia-2022.html"},{"key":"759_CR23","unstructured":"Drug Technical Advisory Board. Agenda for the Sixth Meeting for DTAB to be held in office of Indian Medical Service. New Delhi; 1947 Feb"},{"key":"759_CR24","unstructured":"About IP-. Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 3]. Available from: https:\/\/ipc.gov.in\/mandates\/indian-pharmacopoeia\/about-ip.html"},{"key":"759_CR25","unstructured":"Mission, Vision and Objectives of IPC -. Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 3]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/objectives-of-ipc.html"},{"key":"759_CR26","unstructured":"Indian Pharmacopoeia Commission. History of pharmacopoeia in India [Internet]. IP Online. [cited 2024 Oct 6]. Available from: https:\/\/iponline.ipc.gov.in\/jspui\/indian-pharmacopoeia\/history.jsp"},{"key":"759_CR27","doi-asserted-by":"crossref","unstructured":"Agarwal NB, Karwa M. Pharmaceutical regulations in India. Pharmaceutical Medicine and Translational Clinical Research. Elsevier Inc.; 2017. pp. 215\u201331.","DOI":"10.1016\/B978-0-12-802103-3.00013-4"},{"key":"759_CR28","doi-asserted-by":"crossref","unstructured":"De A, De S, Saha N, Das B, Naskar S, Samanta A. Pharmacopoeias, national formulary and extra pharmacopoeia. In: Nayak AK, Sen KK, editors. Dosage Forms, Formulation Developments and Regulations [Internet]. Elsevier; 2024. pp. 83\u201398.","DOI":"10.1016\/B978-0-323-91817-6.00011-5"},{"key":"759_CR29","unstructured":"TRS 996 -. Annex 1: WHO good pharmacopoeial practices [Internet]. [cited 2024 Sep 30]. Available from: https:\/\/www.who.int\/publications\/m\/item\/trs996-annex1"},{"key":"759_CR30","unstructured":"Expert Committees and Working Groups. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/composition-of-ipc\/8-category-en\/280-expert-committees-and-working-groups.html"},{"key":"759_CR31","unstructured":"IP Online [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/iponline.ipc.gov.in\/jspui\/reference-substances\/"},{"key":"759_CR32","unstructured":"Governing Body -. Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/composition-of-ipc\/8-category-en\/276-governing-body.html"},{"key":"759_CR33","doi-asserted-by":"crossref","unstructured":"Kumar R. Indian Pharmacopoeia Commission \u2019 s Partners for Promoting Public Health Advances in Pharmacoepidemiology & Drug Safety Indian Pharmacopoeia Commission \u2019 s Partners for Promoting Public Health. 2020;(January 2015).","DOI":"10.4172\/2167-1052.1000181"},{"issue":"1","key":"759_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11192-006-0088-y","volume":"68","author":"KC Garg","year":"2006","unstructured":"Garg KC, Kumar S, Lal K. Scientometric profile of Indian agricultural research as seen through Science Citation Index expanded. Scientometrics. 2006;68(1):151\u201366.","journal-title":"Scientometrics"},{"issue":"2","key":"759_CR35","first-page":"212","volume":"9","author":"SG Suke","year":"2015","unstructured":"Suke SG. Indian Pharmacopoeia Commission: structure and role in Formulation of IP and NFI. Int J Med Health Biomedical Bioeng Pharm Eng. 2015;9(2):212\u20136.","journal-title":"Int J Med Health Biomedical Bioeng Pharm Eng"},{"key":"759_CR36","unstructured":"Indian Pharmacopoeia Commission. Composition of the Scientific Body of Indian Pharmacopoeia Commission, Ghaziabad 2024\u201325 [Internet]. 2024 [cited 2025 Feb 5]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/composition-of-ipc\/8-category-en\/279-scientific-body.html"},{"key":"759_CR37","unstructured":"Homepage| Council of Scientific &. Industrial Research [Internet]. [cited 2024 Oct 8]. Available from: https:\/\/www.csir.res.in\/"},{"key":"759_CR38","unstructured":"Overview of What We Do| Indian Council of Medical Research.| Government of India [Internet]. [cited 2024 Oct 8]. Available from: https:\/\/www.icmr.gov.in\/overview-of-what-we-do"},{"key":"759_CR39","doi-asserted-by":"crossref","unstructured":"P B. The Comparative Study of Different Pharmacopoeias. Indian Pharmacopoeia, British Pharmacopoeia, United States Pharmacopoeia. Open Access J Pharm Res. 2023;7(3).","DOI":"10.23880\/oajpr-16000285"},{"key":"759_CR40","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.biologicals.2023.101665","volume":"83","author":"B Poojary","year":"2023","unstructured":"Poojary B, Viviani L, Sengupta A, Kalaivani M, Verma SR, Teng V, et al. Future of TABST and LABST in the Indian Pharmacopoeia Monographs a Humane Society International\/India Workshop Report. Biologicals. 2023;83:101665. (May 2022).","journal-title":"Biologicals"},{"key":"759_CR41","unstructured":"General Body -. Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/composition-of-ipc\/8-category-en\/277-general-body.html"},{"key":"759_CR42","unstructured":"Ghosh R. Institute for Defence Studies and Analyses. Defence research and development: international approaches for analysing the Indian programme. 2015. 52 p."},{"key":"759_CR43","unstructured":"Expert Committees and Working Groups. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Sep 30]. Available from: https:\/\/ipc.gov.in\/8-category-en\/280-expert-committees-and-working-groups.html"},{"key":"759_CR44","unstructured":"Laboratory IP. Ghaziabad, Uttar Pradesh, India - LabGo [Internet]. [cited 2024 Oct 6]. Available from: http:\/\/www.labgo.in\/lab\/indian-pharmacopoeia-commission-indian-pharmacopoeia-laboratory"},{"key":"759_CR45","unstructured":"Indian Pharmacopoeia Laboratory (IPL). - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/indian-pharmacopoeia-laboratory-ipl.html"},{"key":"759_CR46","unstructured":"New Drugs Testing. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/indian-pharmacopoeia-laboratory-ipl\/new-drugs-testing.html"},{"key":"759_CR47","unstructured":"Draft Monographs and Revision. \/ Amendments Proposals for Stakeholders\u2019 Comments - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/news-highlights\/1260-draft-new-chemical-monographs-for-stakeholder-s-comments.html"},{"key":"759_CR48","unstructured":"Release of Guidance Document for Drafting and Formatting of Monographs for Indian Pharmacopoeia. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/news-highlights\/822-guidance-document-for-drafting-and-formatting-of-monographs-for-indian-pharmacopoeia.html"},{"key":"759_CR49","unstructured":"IP Review Process. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/mandates\/indian-pharmacopoeia\/ip-review-process.html"},{"key":"759_CR50","unstructured":"Dosage form monographs required for the following API\u2019s for inclusion in IP -. Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/news-highlights\/179-dosage-form-monographs-required-for-the-following-api-s-for-inclusion-in-ip.html"},{"key":"759_CR51","unstructured":"Submission of New Monographs for IP. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/news-highlights\/177-submission-of-new-monographs-for-ip.html"},{"key":"759_CR52","unstructured":"IP Online [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/iponline.ipc.gov.in\/jspui\/about\/composition-of-ipc.jsp"},{"key":"759_CR53","unstructured":"Draft New General Chapter \/ Monographs. - For Comments - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/mandates\/indian-pharmacopoeia\/monographs\/monographs-under-preparation.html"},{"key":"759_CR54","unstructured":"Mission, Vision and Objectives of IPC -. Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/about-us\/about-ipc\/objectives-of-ipc.html"},{"key":"759_CR55","unstructured":"Monographs for Comments. - Indian Pharmacopoeia Commission [Internet]. [cited 2024 Oct 6]. Available from: https:\/\/ipc.gov.in\/8-category-en\/282-monographs-for-comments.html"},{"key":"759_CR56","unstructured":"Salient features of IP Addendum 2024. Indian Pharmacopoeia Commission. [Internet]. [cited 4 Feb 2025]. https:\/\/ipc.gov.in\/news-highlights\/1252-release-of-ip-addendum-2024.html"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-025-00759-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:51:24Z","timestamp":1745434284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-025-00759-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1007\/s43441-025-00759-1","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}